AngioDynamics To Report Fiscal 2013 First Quarter Financial Results And Hold Conference Call On October 8, 2012

ALBANY, N.Y., Sept. 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 first quarter financial results on Monday, October 8, 2012, after the close of the U.S. financial markets.

Management will host an investment community conference call beginning at 4:30 p.m. Eastern Time on October 8, 2012, to discuss the results and to answer questions.

To participate in the live call by telephone, please dial +1 (877) 941-9205.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' Web site at http://investors.angiodynamics.com . To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the Web site.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com .

Trademarks

AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact:         AngioDynamics, Inc.         D. Joseph Gersuk, CFO         (800) 772-6446 x1608         jgersuk@AngioDynamics.com                  Investor Relations Contacts:         EVC Group, Inc.         Jamar Ismail/Robert Jones         (415) 568-9348; (646) 201-5447         jismail@evcgroup.com;         bjones@evcgroup.com                  Media Contact:         EVC Group, Inc.         Chris Gale         (646) 201-5431         cgale@evcgroup.com

If you liked this article you might like

Endo international, AngioDynamics Lead Biotech Movers

Endo international, AngioDynamics Lead Biotech Movers

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

5 Stocks Everyone Hates -- but You Should Love

5 Stocks Everyone Hates -- but You Should Love

AngioDynamics (ANGO) Strong On High Relative Volume Today

AngioDynamics (ANGO) Strong On High Relative Volume Today

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love